اخبار و اعلانات
آمار
| تعداد نشریات | 20 |
| تعداد شماره‌ها | 404 |
| تعداد مقالات | 3,309 |
| تعداد مشاهده مقاله | 4,751,964 |
| تعداد دریافت فایل اصل مقاله | 3,214,001 |
غربالگری بیوانفورماتیکی بازدارنده‌های آلفاآمیلاز و آلفاگلوکوزیداز از ترکیبات مؤثر گیاهان دارویی زنیان، رازیانه، کلپوره و کاکوتی با استفاده از داکینگ مولکولی به‌منظور درمان بیماری دیابت | ||
| پژوهش های پیشرفته در گیاهان دارویی | ||
| دوره 2، شماره 3 - شماره پیاپی 4، آذر 1402، صفحه 17-31 اصل مقاله (1.75 M) | ||
| نوع مقاله: مقاله علمی- پژوهشی | ||
| شناسه دیجیتال (DOI): 10.30479/armp.2025.21949.1045 | ||
| نویسندگان | ||
| مژگان سلیمانی زاده* 1؛ داوود درویشی زیدآبادی2؛ صفا لطفی3 | ||
| 1استادیار، گروه علوم و مهندسی باغبانی، دانشکده کشاورزی و منابع طبیعی، دانشگاه هرمزگان، بندرعباس | ||
| 2استادیار، بخش تحقیقات جنگل و مرتع، مرکز تحقیقات و آموزش کشاورزی و منابع طبیعی استان کرمان، سازمان تحقیقات، آموزش و ترویج کشاورزی، کرمان | ||
| 3استادیار، گروه بیوتکنولوژی، پژوهشگاه علوم وتکنولوژی پیشرفته و علوم محیطی، دانشگاه تحصیلات تکمیلی صنعتی و فناوری پیشرفته، کرمان | ||
| تاریخ دریافت: 03 اردیبهشت 1404، تاریخ بازنگری: 01 خرداد 1404، تاریخ پذیرش: 10 خرداد 1404 | ||
| چکیده | ||
| بر اساس آخرین گزارش سازمان بهداشت جهانی، تا سال 2030 بیماری دیابت به هفتمین علت اصلی مرگ و میر در سراسر جهان تبدیل خواهد شد. پتانسیل زیادی برای کشف ترکیبات جدید از منابع طبیعی به‌عنوان یک رویکرد پیشگیری و درمان جایگزین که مقرون‌به‌صرفه و با عوارض جانبی کمتر باشد، برای کاهش بار این بیماری همه‌گیر وجود دارد. در طی این پژوهش 38 ترکیب دارویی ارزشمند از 4 گونه دارویی زنیان، رازیانه، کلپوره و کاکوتی جداسازی و اثر ضد دیابت آن‌ها با استفاده از نرم‌افزارهای بیوانفورماتیکی و روش داکینگ مولکولی در مقایسه با شاهد اثبات گردید. با توجه به هزینه‌های درمان مرسوم و اهمیت داروهای با منشأ گیاهی در درمان بیماری‌ها، در این پژوهش ترکیبات دارویی مهم را که می‌توانند برای درمان دیابت استفاده شوند و عاری از عوارض جانبی نامطلوب و اثرات دارویی قوی هستند از گیاهان دارویی با استفاده از روش بیوانفورماتیک جداسازی کرده و بهترین ترکیبات به‌عنوان کاندید برای درمان دیابت معرفی شدند. بالاترین و کمترین انرژی داکینگ به ترتیب مربوط به ترکیب دیوسمین و کامفور است. سپس فلاونوئید لوتئولین بیشترین توانایی را برای اتصال به این آنزیم نشان داد. از ترکیبات شاخص راهگشا برای کنترل و بهبود دیابت می‌توان به دیوسمین، لوتئولین و کوئرسیتین اشاره داشت. | ||
| کلیدواژه‌ها | ||
| بیوانفورماتیک؛ داکینگ مولکولی؛ کاکوتی؛ متابولیت دارویی | ||
| عنوان مقاله [English] | ||
| Bioinformatics screening of alpha-amylase and alpha-glucosidase inhibitors from active compounds of medicinal plants Trachyspermum ammi, Foeniculum vulgare, Teucrium polium, and Ziziphora clinopodioides using molecular docking for diabetes treatment | ||
| نویسندگان [English] | ||
| Mojgan Soleimanizadeh1؛ Davod Darvishi Zeidabadi2؛ Safa Lotfi3 | ||
| 1Assistant Professor, Dept. of Horticultural Science and Engineering, Faculty of Agriculture and Natural Resources, University of Hormozgan, Bandar Abbas, Iran | ||
| 2Assistant Professor, Dept. of Forest and Rangeland Research, Kerman Province Agricultural and Natural Resources Research and Education Center, Agricultural Research, Education and Promotion Organization, Kerman, Iran | ||
| 3Assistant Professor, Dept. of Biotechnology, Institute of Science and High Technology and Environmental Science, Graduate University of Advanced Technology, Kerman, Iran | ||
| چکیده [English] | ||
| According to the latest global report by the World Health Organization, by 2030, the metabolic disorder diabetes will become the seventh leading cause of death worldwide. There is considerable potential in discovering new compounds from natural sources as a cost-effective and low-side-effect alternative approach for the prevention and treatment of this widespread disease. In this study, 38 bioactive compounds were isolated from four medicinal plant species Trachyspermum ammi, Foeniculum vulgare, Teucrium polium, and Ziziphora clinopodioides. Their antidiabetic properties were evaluated using bioinformatics tools and molecular docking methods, compared to standard reference compounds. Given the high costs associated with conventional treatments and the growing importance of plant-derived drugs in modern medicine, this research aimed to identify potent plant-based compounds with minimal adverse effects for potential use in diabetes therapy. Among the evaluated compounds, diosmin exhibited the lowest (most favorable) docking energy, indicating the strongest binding affinity, while camphor showed the highest (least favorable) docking energy. Then, the flavonoid luteolin showed the greatest ability to bind to this enzyme. Key compounds identified as promising candidates for controlling and improving diabetes include diosmin, luteolin, and quercetin. | ||
| کلیدواژه‌ها [English] | ||
| Bioinformatics, Medicinal metabolite, Molecular docking, Ziziphora clinopodioides | ||
| مراجع | ||
|
Adejoro IA, Babatunde DD, Tolufashe GF. 2020. Molecular docking and dynamic simulations of some medicinal plants compounds against SARS-CoV-2: an in silico study. Journal of Taibah University for Science 14 (1): 1563-1570. DOI: https://doi.org/10.1080/16583655.2020.1848049. Afrisham R, Aberomand M, Ghaffari MA, Siahpoosh A, Jamalan M. 2015. Inhibitory effect of Heracleum persicum and Ziziphus jujuba on activity of alpha-amylase. Journal of Botany. DOI: https://doi.org/10.1155/2015/824683. Afsharmanesh MR, Mohammadi Z, Jafari SM. 2024. Iranian medicinal plants in diabetes management: a narrative review of traditional herbal remedies and their hypoglycemic effects. Journal of Food Biochemistry 2024 (1): 6694085. DOI: https://doi.org/10.1155/jfbc/6694085. Alam F, Islam MA, Kamal MA, Gan SH. 2018. Updates on managing type 2 diabetes mellitus with natural products: towards antidiabetic drug development. Current Medicinal Chemistry 25 (39): 5395-5431. DOI: https://doi.org/10.2174/0929867323666160813222436. Alwan A. 2011. Global status report on noncommunicable diseases 2010. World Health Organization. https://iris.who.int/handle/10665/44579. Alizadeh Z, Fattahi M, Farokhzad A, Asghari B, Yousefzadeh-Valendeh S, Alipour H, Palazon J. 2025. Green nanoparticles synthesized from damask rose petals: Evaluation of their antioxidant, antimicrobial, anti-diabetic, anti-Alzheimer, and photocatalytic properties. Heliyon, 11 (4): e42557. DOI: https://doi.org/10.1016/j.heliyon.2025.e42557. Association AD. 2018. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes—2018. Diabetes Care, 41 (Supplement_1): S13-S27. DOI: https://doi.org/10.2337/dc18-S002. Buse JB, Wexler DJ, Tsapas A, Rossing P, Mingrone G, Mathieu C, D’Alessio DA, Davies MJ. 2020. 2019 update to: management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 43 (2): 487-493. DOI: https://doi.org/10.2337/dci19-0066. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. 2003. β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 52 (1): 102-110. DOI: https://doi.org/10.2337/diabetes.52.1.102. Chakrabarti R, Rajagopalan R. 2002. Diabetes and insulin resistance associated disorders: disease and the therapy. Current Science Association 83 (12): 1533-1538. Cho NH, Shaw J, Karuranga S, Huang Y, da Rocha Fernandes J, Ohlrogge A, Malanda B. 2018. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Research and Clinical Practice 138: 271-281. DOI: https://doi.org/10.1016/j.diabres.2018.02.023. Cnop M, Welsh N, Jonas J-C, Jorns A, Lenzen S, Eizirik DL. 2005. Mechanisms of pancreatic β-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54 (suppl_2): S97-S107. DOI: https://doi.org/10.2337/diabetes.54.suppl_2.s97. Doyle-Delgado K, Chamberlain JJ, Shubrook JH, Skolnik N, Trujillo J. 2020. Pharmacologic approaches to glycemic treatment of type 2 diabetes: synopsis of the 2020 American diabetes association's standards of medical care in diabetes clinical guideline. Annals of Internal Medicine, 173 (10): 813-821. DOI: https://doi.org/10.7326/m20-2470. Eden Miller D, Aguilar RB, Schwartz SS. 2019. Type 2 diabetes: evolving concepts and treatment. Cleveland Clinic Journal of Medicine 86 (7): 494-504. DOI: https://doi.org/10.3949/ccjm.86a.17107. Erener S. 2020. Diabetes, infection risk and COVID-19. Molecular Metabolism 39: 101044. DOI: https://doi.org/10.1016/j.molmet.2020.101044. Fu Z, Gilbert ER, Liu D. 2013. Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes. Current Diabetes Reviews 9 (1): 25-53. Gerich JE. 1993. Control of glycaemia. Bailliere's Clinical Endocrinology and Metabolism 7 (3): 551-586. DOI: https://doi.org/10.1016/s0950-351x(05)80207-1. Gheissari A, Hemmatzadeh S, Merrikhi A, Tehrani SF, Madihi Y. 2012. Chronic kidney disease in children: A report from a tertiary care center over 11 years. Journal of Nephropathology 1 (3): 177-182. DOI: https://doi.org/10.5812/nephropathol.8119. Ghosal S, Arora B, Dutta K, Ghosh A, Sinha B, Misra A. 2020. Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: a cohort analysis. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 14 (5): 949-952. DOI: https://doi.org/10.1016/j.dsx.2020.06.020. Greiner EF, Guppy M, Brand K. 1994. Glucose is essential for proliferation and the glycolytic enzyme induction that provokes a transition to glycolytic energy production. Journal of Biological Chemistry 269 (50): 31484-31490. DOI: https://doi.org/10.1016/S0021-9258(18)31720-4. Grunberger G. 2017. Should side effects influence the selection of antidiabetic therapies in type 2 diabetes? Current Diabetes Reports 17 (4): 21. DOI: https://doi.org/10.1007/s11892-017-0853-8. Kalra S. 2014. Alpha glucosidase inhibitors. JPMA: The Journal of the Pakistan Medical Association 64 (4): 474-476. Kooti W, Moradi M, Ali-Akbari S, Sharafi-Ahvazi N, Asadi-Samani M, Ashtary-Larky D. 2015. Therapeutic and pharmacological potential of Foeniculum vulgare Mill: a review. Journal of HerbMed Pharmacology 4 (1): 1-9. Lagunin AA, Goel RK, Gawande DY, Pahwa P, Gloriozova TA, Dmitriev AV, Ivanov SM, Rudik AV, Konova VI, Pogodin PV. 2014. Chemo-and bioinformatics resources for in silico drug discovery from medicinal plants beyond their traditional use: a critical review. Natural Product Reports 31 (11): 1585-1611. DOI: https://doi.org/10.1039/c4np00068d. Laskowski RA, Swindells MB. 2011. LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. Journal of Chemical Information and Modeling 51 (10): 2778-2786. DOI: https://doi.org/10.1021/ci200227u. Lordan S, Smyth TJ, Soler-Vila A, Stanton C, Ross RP. 2013. The α-amylase and α-glucosidase inhibitory effects of Irish seaweed extracts. Food Chemistry 141 (3): 2170-2176. DOI: https://doi.org/10.1016/j.foodchem.2013.04.123. Mohammadi E, Abdi F. 2025. Medicinal plants effective on diabetes in northwest of Iran. Plant Biotechnology Persa 7 (1): 4-9. DOI: http://dx.doi.org/10.61186/pbp.7.1.3. Nyenwe EA, Jerkins TW, Umpierrez GE, Kitabchi AE. 2011. Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes. Metabolism 60 (1): 1-23. DOI: https://doi.org/10.1016/j.metabol.2010.09.010. Organization WH. 2006. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation. World Health Organization. https://iris.who.int/handle/10665/43588. Parohan M, Yaghoubi S, Seraji A, Javanbakht MH, Sarraf P, Djalali M. 2020. Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. The Aging Male 23 (5): 1416-1424. DOI: https://doi.org/10.1080/13685538.2020.1774748. Perla V, Jayanty SS. 2013. Biguanide related compounds in traditional antidiabetic functional foods. Food Chemistry 138 (2-3): 1574-1580. DOI: https://doi.org/10.1016/j.foodchem.2012.09.125. Poovitha S, Parani M. 2016. In vitro and in vivo α-amylase and α-glucosidase inhibiting activities of the protein extracts from two varieties of bitter gourd (Momordica charantia L.). BMC Complementary and Alternative Medicine 16 Suppl 1 (Suppl 1): 185. DOI: https://doi.org/10.1186/s12906-016-1085-1. Read PA, Khan FZ, Heck PM, Hoole SP, Dutka DP. 2010. DPP-4 inhibition by sitagliptin improves the myocardial response to dobutamine stress and mitigates stunning in a pilot study of patients with coronary artery disease. Circulation: Cardiovascular Imaging 3 (2): 195-201. DOI: https://doi.org/10.1161/circimaging.109.899377. Ren L, Qin X, Cao X, Wang L, Bai F, Bai G, Shen Y. 2011. Structural insight into substrate specificity of human intestinal maltase-glucoamylase. Protein Cell 2 (10): 827-836. DOI: https://doi.org/10.1007/s13238-011-1105-3. Rolta R, Salaria D, Kumar V, Patel CN, Sourirajan A, Baumler DJ, Dev K. 2022. Molecular docking studies of phytocompounds of Rheum emodi Wall with proteins responsible for antibiotic resistance in bacterial and fungal pathogens: in silico approach to enhance the bio-availability of antibiotics. Journal of Biomolecular Structure and Dynamics 40 (8): 3789-3803. DOI: https://doi.org/10.1080/07391102.2020.1850364. Rudenski A, Hadden D, Atkinson A, Kennedy L, Matthews D, Merrett J, Pockaj B, Turner R. 1988. Natural history of pancreatic islet B‐cell function in type 2 diabetes mellitus studied over six years by homeostasis model assessment. Diabetic Medicine 5 (1): 36-41. DOI: https://doi.org/10.1111/j.1464-5491.1988.tb00938.x. Rudnitskaya A, Török B, Török M. 2010. Molecular docking of enzyme inhibitors: A Computational tool for structure-based drug design. Biochemistry and Molecular Biology Education 38 (4): 261-265. DOI: https://doi.org/10.1002/bmb.20392. Saad B, Said O. 2011. Greco-Arab and Islamic herbal medicine: traditional system, ethics, safety, efficacy, and regulatory issues. John Wiley & Sons. DOI: http://doi.org/10.1002/9780470944363. Sadeghi M, Zarei MA. 2021. Molecular docking studies of some flavone analogues as α-Glucosidase inhibitors. Journal of Medicinal Plants 19: 55-64. DOI: http://dx.doi.org/10.29252/jmp.19.75.55. Salehi B, Ata A, V Anil Kumar N, Sharopov F, Ramirez-Alarcon K, Ruiz-Ortega A, Abdulmajid Ayatollahi S, Valere Tsouh Fokou P, Kobarfard F, Amiruddin Zakaria Z. 2019. Antidiabetic potential of medicinal plants and their active components. Biomolecules 9 (10): 551. DOI: https://doi.org/10.3390/biom9100551. Scheen AJ, Paquot N. 2013. Metformin revisited: A critical review of the benefit–risk balance in at-risk patients with type 2 diabetes. Diabetes & Metabolism 39 (3): 179-190. DOI: https://doi.org/10.1016/j.diabet.2013.02.006. Sharma R, Arya V. 2011. A review on fruits having anti-diabetic potential. Journal of Chemical and Pharmaceutical Research 3 (2): 204-212. Singab AN, Youssef FS, Ashour M. 2014. Medicinal plants with potential antidiabetic activity and their assessment. Medicinal & Aromatic Plants 3 (151): 2167-0412. DOI: http://dx.doi.org/10.4172/2167-0412.1000151. Stumvoll M, Goldstein BJ, van Haeften TW. 2008. Type 2 diabetes: pathogenesis and treatment. The Lancet 371 (9631): 2153-2156. DOI: https://doi.org/10.1016/s0140-6736(08)60932-0. Sledz P, Caflisch A. 2018. Protein structure-based drug design: from docking to molecular dynamics. Current Opinion in Structural Biology 48: 93-102. DOI: https://doi.org/10.1016/j.sbi.2017.10.010. Trott O, Olson AJ. 2010. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry 31 (2): 455-461. DOI: https://doi.org/10.1002/jcc.21334. Udler MS. 2019. Type 2 diabetes: multiple genes, multiple diseases. Current Diabetes Reports 19 (8): 55. DOI: https://doi.org/10.1007/s11892-019-1169-7. Williams LK, Zhang X, Caner S, Tysoe C, Nguyen NT, Wicki J, Williams DE, Coleman J, McNeill JH, Yuen V, Andersen RJ, Withers SG, Brayer GD. 2015. The amylase inhibitor montbretin A reveals a new glycosidase inhibition motif. Nature Chemical Biology 11 (9): 691-696. DOI: https://doi.org/10.1038/nchembio.1865. Van de Laar F, Lucassen P, Akkermans R, Van de Lisdonk E, Rutten G, Van Weel C. 2005. Alpha-glucosidase inhibitors for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews. DOI: https://doi.org/10.1002/14651858.CD003639.pub2. Yousefzadeh-Valendeh S, Fattahi M, Asghari B, Alizadeh Z. 2023. Dandelion flower-fabricated Ag nanoparticles versus synthetic ones with characterization and determination of photocatalytic, antioxidant, antibacterial, and α-glucosidase inhibitory activities. Scientific Reports 13: 15444. DOI: https://doi.org/10.1038/s41598-023-42756-0. Zhang Y, Ma ZF. 2020. Impact of the COVID-19 pandemic on mental health and quality of life among local residents in Liaoning Province, China: A cross-sectional study. International Journal of Environmental Research and Public Health 17 (7): 2381. DOI: https://doi.org/10.3390/ijerph17072381. | ||
|
آمار تعداد مشاهده مقاله: 56 تعداد دریافت فایل اصل مقاله: 17 |
||